Symrise AG (ETR:SY1)
73.44
-0.30 (-0.41%)
Apr 28, 2026, 5:35 PM CET
Symrise AG Revenue
In the year 2025, Symrise AG had annual revenue of 4.93B EUR, down -1.39%. Symrise AG had revenue of 2.38B in the half year ending December 31, 2025, with 2.55% growth.
Revenue
4.93B
Revenue Growth
-1.39%
P/S Ratio
2.07
Revenue / Employee
388.22K
Employees
12,971
Market Cap
10.18B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 4.93B | -69.23M | -1.39% |
| Dec 31, 2024 | 5.00B | 268.33M | 5.67% |
| Dec 31, 2023 | 4.73B | 111.71M | 2.42% |
| Dec 31, 2022 | 4.62B | 792.79M | 20.72% |
| Dec 31, 2021 | 3.83B | 305.24M | 8.67% |
| Dec 31, 2020 | Pro | Pro | Pro |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Brenntag SE | 15.17B |
| Covestro AG | 12.94B |
| Evonik Industries AG | 14.07B |
| Wacker Chemie AG | 5.49B |
| Fuchs SE | 3.56B |
| Verbio SE | 1.73B |
| AlzChem Group AG | 575.05M |
| LANXESS Aktiengesellschaft | 5.67B |
Symrise AG News
- 8 days ago - EQS-PVR: Symrise AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution - Wallstreet:Online
- 7 weeks ago - Symrise AG Earnings Call Transcript: Q4 2025 - Transcripts
- 6 months ago - Symrise AG Earnings Call Transcript: Q3 2025 - Transcripts
- 7 months ago - Symrise and Aplantex Confirm an Agreement to Establish a Partnership - Business Wire
- 9 months ago - Symrise AG Earnings Call Transcript: Q2 2025 - Transcripts
- 1 year ago - Symrise AG Earnings Call Transcript: Q1 2025 - Transcripts
- 1 year ago - Hofseth Biocare ASA: HBC ACCELERATES IN HUMAN HEALTH AND PET NUTRITION THROUGH A STRATEGIC PARTNERSHIP WITH SYMRISE TO BUILD OUT BERKÅK, TRIPLING THE MANUFACTURING CAPACITY OF THE GROUP - GlobeNewsWire
- 1 year ago - Symrise AG Earnings Call Transcript: Q4 2024 - Transcripts